The biology of intelligence: From association to mechanism

Intelligence

Volumn 26, Issue 2, 1998, Pages 63-73

  MacLullich, Alasdair M J ^b   Seckl, Jonathan R ^b   Starr, John M ^b   Deary, Ian J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032325543     PISSN: 01602896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0160-2896(99)80053-1     Document Type: Editorial

References (66)

1. Alberts, M.J., Graffagnino, C., McClenny, C., Strittmatter, W., Saunders, A.M., & Roses, A.D. (1995). ApoE genotype and survival from intracerebral haemorrhage. Lancet, 346, 575.
2. Beck-Nielsen, H., & Groop, L.C. (1994). Metabolic and genetic characterisation of prediabetic states. Journal of Clinical Investigation, 94, 1714-1721.
3. Blacker, D., Haines, J.L., Rodes, L., Terwedow, H., Go, R.C.P., Harrell, L.E., Perry, R.T., Bassett, S.S., Chase, G., Meyers, D., Albert, M.S., & Tanzi, R. (1997). ApoE-4 and age at onset of Alzheimer's disease: the NIMH Genetics Initiative. Neurology, 48, 139-147.
4. Blennow, K., & Cowburn, R.F. (1996). The neurochemistry of Alzheimer's disease. Acta Neurologica Scandinavica, Suppl 168, 77-86.
5. Bondi, M.W., Salmon, D.P., Monsch, A.U., Galasko, D., Butters, N., Klauber, M.R., Thal, L.J., & Saitoh, T. (1995). Episodic memory changes are associated with the APOE-ε4 allele in nondemented older adults. Neurology, 45, 2203-2206.
6. Bowen, J., Teri, L., Kukull, W., McCormick, W., McCurry, S.M., & Larson, E.B. (1997). Progression to dementia in patients with isolated memory loss. Lancet, 349, 763-65.
7. Brody, N. (1992). Intelligence (2nd ed.). Academic Press: San Diego
8. Carroll, J.B. (1993). Human cognitive abilities. A survey of factor analytic studies. Cambridge University Press: New York.
9. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., & Preicak-Vance, M.A. (1993). Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261, 921-923.
10. Deary, I.J, & Caryl, P.G. (1997). Neuroscience and human intelligence differences. Trends in Neurosciences, 20, 365-371.
11. Deary, I.J., & Stough, C. (1996). Intelligence and inspection time: achievements, prospects and problems. American Psychologist, 51, 599-608.
12. Eslinger, P.J., Damasio, A.R., Benton, A.L., & Van Allen, M. (1985). Neuropsychologic detection of abnormal mental decline in older persons. Journal of the Americal Medical Association, 253, 670-674.
13. Farber, J.F., Schmitt, F.A., & Logue, F.E. (1988). Predicting intellectual level from the Mini-Mental State Examination. Journal of the American Geriatrics Society, 36, 509-510.
14. Feskens, E.J.M., Havekes, L.M., Kalmijn, S., de Knijff, P., Launer, L.J., & Kromhout, D. (1994) Apolipoprotein ε4 allele and cognitive decline in elderly men. British Medical Journal, 309, 1202-1206.
15. Folstein, M.F., Folstein, S.E., & McHugh, P.R. (1975). Mini mental state. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-98.
16. Gelder, M., Gath, D., Mayou, R., & Cowen, P. (1996). Oxford Textbook of Psychiatry (3rd ed.). Oxford University Press: Oxford.
17. Ghosh, S., & Schork, N.J. (1996). Genetic analysis of NIDDM. The study of quantitative traits. Diabetes, 45, 1-14.
18. Helkala, E.L., Koivisto, K., Hanninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., Mykkanen, L., Kesaniemi, Y.A., Laakso, M., & Riekkinnen, P. Sr. (1995). The association of apolipoprotein E polymorphism with memory: A population based study. Neuroscience Letters, 191, 141-144.
19. Helkala, E.L., Koivisto, K., Hanninen, T., Vanhanen, M., Kervinen, K., Kuusisto, J., Mykkanen, L., Kesaniemi, Y.A., Laakso, M., & Riekkinen, P. Sr. (1996). Memory functions in human subjects with different apolipoprotein phenotypes during a 3-year population-based follow-up study. Neuroscience Letters, 204, 177-180.
20. Highfield, R. (1997). Scientists discover gene that creates human intelligence. Daily Telegraph, 10-31-1997, p. 14.
21. Hyman, B.T., Gomez-Isla, T., Briggs, M., Chung, H., Nichols, S., Kohout, F., & Wallace, R. (1996). Apolipoprotein E and cognitive change in an elderly population. Annals of Neurology, 40, 55-66.
22. Kalmijn, S., Feskens, E.J.M., Launer, L.J., Stijnen, T., & Kromhout, D. (1995). Glucose intolerance, hyperinsulinaemia and cognitive function in a general population of elderly men. Diabetalogia, 38, 1096-1102.
23. Kamboh, M.I., Aston, C.E., Ferrel, R.E., & Hamman, R.F. (1993). Impact of apolipoprotein E polymorphism in determining interindividual variation in total cholesterol and low density lipoprotein cholesterol in Hispanics and non-Hispanic whites. Atherosclerosis, 98, 201-211.
24. Krugers, H.J., Mulder, M., Korf, J., Havekes, L., de Kloet, E.R., & Joels, M. (1997). Altered synaptic plasticity in hippocampal area of apolipoprotein E deficient mice. NeuroReport, 8, 2505-2510.
25. Kuusisto, J., Koivisto, K., Mykkanen, L., Helkala, E.L., Vanhanen, M., Hanninen, T., Pyorala, L., Riekkinnen, P., & Laakso, M. (1993). Essential hypertension and cognitive function. The role of hyperinsulinaemia. Hypertension, 22, 771-779.
26. LaDu, M.J., Falduto, M.T., Manelli, A.M., Reardon, C.A., Getz, G.S., & Frail, D.E. (1994). Isoform-specific binding of apolipoprotein E to b-amyloid. Journal of Biological Chemistry, 269, 23403-23406.
27. Lehtovirta, M., Laakso, M.P., Soininen, H., Helisalmi, S., Mannermaa, A., Helkala, E.L., Partanen, K., Ryynanen, M., Vainio, P., Hartikainen, P., & Riekkinen, P.J. Sr. (1995). Volumes of hippocampus, amygdala and frontal lobe in Alzheimer patients with different apolipoprotein E genotypes. Neuroscience, 67, 65-72.
28. Lezak, M.D. (1995). Neuropsychological assessment. Oxford University Press: Oxford.
29. Linn, R.T., Wolf, P.A., Bachman, D.L., Knoefel, J.E., Cobb, J.L., Belanger, A.J., Kaplan, E.F., & D'Agostino, R.B. (1995). The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Archives of Neurology, 52, 485-490.
30. Mann, D.M.A., Brown, A.M.T., Prinja, D., Jones, D., & Davies, C.A. (1990). A morphological analysis of senile plaques in the brains of non-demented persons of different ages using silver, immunocytochemical and lectin histochemical staining techniques. Neuropathology and Applied Neurobiology, 16, 17-25.
31. Mark, R.J., Lovell, M.A., Markesbery, W.R., Uchida, K., & Mattson, M.P. (1997). A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, indisruption of ion homeostasis and neuronal death induced by amyloid β-peptide. Journal of Neurochemistry, 68, 255-264.
32. Masliah, E., Mallory, M., Ge, N., Alford, M., Veinbergs, I., & Roses, A.D. (1995). Neurodegeneration in the central nervous system of apo-E deficient mice. Experimental Neurology, 136, 107-22.
33. Mayeux, R., Ottman, R., Maestre, G., Ngai, C., Tang, M.X., Ginsberg, H., Chun, M., Tycko, B., & Shelanski, M. (1995). Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease. Neurology, 45, 555-557.
34. McCartney, K., Harris, M.J., & Bernieri, F. (1990). Growing up and growing apart: A developmental meta-analysis of twin studies. Psychological Bulletin, 107, 226-237.
35. Mortimer, J.A., Van Duijin, C.N., Chandra, V., Fratiglioni, L., Graves, A.B., Heyman, A., Jorm, A.F., Kokmen, E., Kondo, K., Rocca, W.A., Shalat, S.L., Soininen, H.S., & Hofman, A. (1991). Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. International Journal of Epidemiology, 20 (Suppl 2), S28-S35.
36. Nakata, Y., Katsuya, T., Rakugi, H., Takami, S., Ohishi, M., Kamino, K., Higaki, J., Tabuchi, Y., Kumahara, Y., Miki, T., & Ogihara, T. (1996). Polymorphism of the apolipoprotein E gene and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischaemia. Hypertension, 27, 1205-1209.
37. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W., & Pitas, R.E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science, 264, 850-852.
38. Newman, M.F., Croughwell, N.D, Blumenthal, J.A., Lowry, E., White, W.D., Spillane, W., Davis, R.D., Glower, D.D., Smith, L.R., Mahanna, E.P., & Reves, J.G. (1995). Predictors of cognitive decline after cardiac operation. Annals of Thoracic Surgery, 59, 1326-1330.
39. Nicoll, J.A.R. (1996). Genetics and head injury. Neuropathology and Applied Neurobiology, 22, 515-517.
40. Nicoll, J.A.R., Roberts G.W., & Graham, D.I. (1995). Apolipoprotein E ε4 allele is associated with deposition of amyloid b-protein following head injury. Nature Medicine, 1, 135-137.
41. Pedersen, N.L., Plomin, R., Nesselroade, J.R., & McCleara, G.E. (1992). A quantitatively genetic analysis of cognitive abilities during the second half of the life span. Psychological Science, 3, 346-353.
42. Plassman, B.L., Welsh-Bohmer, K.A., Bigler, E.D., Johnson, S.C., Anderson, C.V., Helms, M.J., Saunders A.M., & Breitner, J.C.S. (1997). Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition. Neurology, 48, 985-989.
43. Plomin, R., Pedersen, N.L., Lichenstein, P., & McClearn, G.E. (1994a). Variability and stability in cognitive abilities are largely genetic later in life. Behavior Genetics, 24, 207-215.
44. Plomin, R., McClearn, G.E., Smith, D.L., Vignetti, S., Chorney, M.J., Chorney, K., Venditti, C.P., Kasarda, S., Thompson, L.A., Detterman, D.K., Daniels, J., Owen, M., & McGuffin, P. (1994b). DNA markers associated with high versus low IQ: the IQ Quantitative Loci (QTL) Project. Behavior Genetics, 24, 107-118.
45. Plomin, R., DeFries, J.C., McClearn, G.E., & Rutter, M. (1997). Behavioral genetics (3rd Ed.). W.H. Freeman: New York.
46. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends in Neurosciences, 17, 525-530.
47. Reed, T., Carmelli, D., Swan, G.E., Breitner, J.C.S., Welsh, K.A., Jarvik, G.P., Deeb, S., & Auwerx, J. (1994). Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E ε4 allele. Archives of Neurology, 51, 1189-1192.
48. Reiman, E.M., Caselli, R.J., Yun, L.S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S.N., & Osborne, D. (1996). Preclinical evidence of Alzheimer's disease in persons homozygous for the ε4 allele for apolipoprotein E. New England Journal of Medicine, 334, 752-758.
49. Roses, A.D. (1996). Apolipoprotein E in neurology. Current Opinion in Neurology, 9, 265-270.
50. Rutter, M., & Plomin, R. (1997). Opportunities for psychiatry from genetic findings. British Journal of Psychiatry, 171, 209-219.
51. Seckl, J.R., & Olsson, T. (1995). Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect? Journal of Endocrinology, 145, 201-211.
52. Seshadri, S., Drachman, D.A., & Lippa, C.F. (1995). Apolipoprotein E ε4 allele and the lifetime risk of Alzheimer's disease. Archives of Neurology, 52, 1074-1079.
53. Smith, C.U.M. (1996). Elements of molecular neurobiology (2nd ed.). Wiley: Chichester.
54. Soininen, H.S., Partanen, K., Pitkanen, A., Hallikainen, M., Hanninen, T., Helisalmi, S., Mannermaa, A., Ryynanen, M., Koivisto, K., & Reikkinen, P. Sr. (1995). Decreased hippocampal volume asymmetry on MRIs in nondemented elderly subjects carrying the apolipoprotein E ε4 allele. Neurology, 45, 391-392.
55. Soininen, H.S., & Riekkinen, P.J. Sr. (1996). Apolipoprotein E, memory and Alzheimer's disease. Trends in Neurosciences, 19, 224-228.
56. Spearman, C. (1923). The nature of 'intelligence' and the principles of cognition. London: Macmillan.
57. Stengard, J.H., Zerba, K.E., Pekkanen, J., Ehnholm, C., Nissinen, A., & Sing, C.F. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation, 91, 265-269.
58. Strachan, M.W.J., Deary, I.J., Ewing, F.M.E., & Frier, B.M. (1997). Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care, 20, 438-445.
59. Tardiff, B., Newman, M., Saunders, A., Strittmatter, W., White, W., Smith, L.R., Roses, A.D., & Reves, G. (1994). Apolipoprotein E allele frequency in patients with cognitive deficits following cardiopulmonary bypass. Circulation, 90 (Suppl 1), 201.
60. Terry, J.G., Howard, G., Mercuri, M., Bond, M.G., & Crouse, J.R. (1996). Apolipoprotein E polymorphism is associated with segment-specific extracranial carotid artery intima-media thickening. Stroke, 27, 1755-1759.
61. Tolar, M., Marques, M.A., Harmony, J.A.K., & Crutcher, K.A. (1997). Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor mediated. Journal of Neuroscience, 17, 5678-5686.
62. Vanhanen, M., Koivistom K., Karjalainen, L., Helkala, E.L., Laakso, M., Soininen, H., & Riekkinen, P. Sr. (1997). Risk for non-insulin dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. NeuroReport, 8, 1527-1530.
63. Yaffe, K., Cauley, J., Sands, L., & Browner, W. (1997). Apolipoprotein E phenotype and cognitive decline ina prospective study of elderly community women. Archives of Neurology, 54, 1110-1114.
64. Yamauchi, H., Fukuyama, H., Katsumi, Y., Dong, Y., Konishi, J., & Kimura, J. (1996). Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease. Archives of Neurology, 53, 1103-1109.
65. Yankner, B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron, 16, 921-932.
66. Yen, S.H., Liu, W.K., Hall, F.L., Yan, S.D., Stern, D., & Dickson, D.W. (1995). Alzheimer neurofibrillary lesions: molecular nature and potential roles of different components. Neurobiology of Aging, 16, 381-387.